PANCREATIC INTRADUCTAL NEOPLASMS

Clinical trials for PANCREATIC INTRADUCTAL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new PANCREATIC INTRADUCTAL NEOPLASMS trials appear

Sign up with your email to follow new studies for PANCREATIC INTRADUCTAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radioactive 'Trojan Horse' drug targets Hard-to-Treat cancers

Disease control Recruiting now

This early-stage study is testing a new radioactive cancer drug called LY4337713 in adults with advanced solid tumors that have spread. The drug is designed to seek out and deliver radiation directly to cancer cells that have a specific protein marker called FAP. Researchers will…

Matched conditions: PANCREATIC INTRADUCTAL NEOPLASMS

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

PANCREATIC INTRADUCTAL NEOPLASMS

Get alerted when new PANCREATIC INTRADUCTAL NEOPLASMS trials appear

Radioactive 'Trojan Horse' drug targets Hard-to-Treat cancers